Thrombocytosis is a paraneoplastic syndrome of ovarian cancer, and the mechanism is mainly explained by the higher plasma levels of thrombopoietin and IL-6 in patients with thrombocytosis compared to those without thrombocytosis [34]. This evidence concerns the gene THPO and thrombocytosis disease.